Furthermore, ontogeny data for proteins implicated in ASO-induced thrombocytopenia mechanisms, such as GPVI and PF4, are pivotal to extending the work to juvenile minipigs as a nonclinical safety model for pediatric drug development. Here, GP6 is linked to Thrombocytopenia.